Extracorporeal Membrane Oxygenation Machine Market Size, Competitive Landscape and Market Forecast - 2029

SKU: DMMD2218 | Last Updated On: Nov 29 2021 | Available Formats

> Global Extracorporeal Membrane Oxygenation Machine Market Expected to reach a high CAGR of 4.7% By 2028: DataM Intelligence

Global Extracorporeal Membrane Oxygenation Machine Market is segmented By Modality Type (Veno-arterial, Veno-venous, Arterio-venous), By Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation), By Component (Pumps, Oxygenators, Controllers, Cannula, Accessories), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2021-2028

 

Market Overview

The Global "Extracorporeal Membrane Oxygenation Machine Market" is expected to grow at a CAGR of 4.7% during the forecasting period (2021-2028).

An extracorporeal membrane oxygenation machine also known as a life support machine is used in the treatment of various heart and lung diseases. The main purpose of an extracorporeal membrane oxygenation machine is to provide enough oxygen to the body when the heart and lungs are not functioning properly. This machine is used worldwide for the treatment of lung cancer and chronic disorders.

Market Dynamics

The Extracorporeal Membrane Oxygenation Machine market is driven by various factors such as rising prevalence rates of lung cancer, increasing geriatric population, improvements in ECMO technology are expected to be other driving forces for the ECMO machine market over 2020-2027.

The growth of the market can also be attributed to the rising number of ECMO centers, conferences, and training programs to increase awareness about the technology. Moreover, the availability of technologically advanced devices by key players is also expected to play a vital role in the growth of the market.

According to the WHO, chronic obstructive pulmonary disease (COPD) affects nearly 200 million people globally. Today, rising funding by government organizations for the treatment of chronic diseases will boost market growth.

For instance, in European Union the direct cost of COPD is around 6% of total health expenditure, accounting for nearly 56% of the total cost of respiratory diseases. Another, driving factor for the extracorporeal membrane oxygenation market is the high adoption rate of ECMO techniques for lung transplantation. Thus, increasing awareness about extracorporeal membrane oxygenation techniques among the patients and in hospitals will provide market players with better opportunities in the future. 

Market Segmentation

Based on Modality, the global Extracorporeal Membrane Oxygenation Machine market is segmented into Veno-arterial (VA), Veno-venous (VV), and Arterio-venous (AV). These modalities are used to provide hemodynamic support and to facilitate gaseous exchange in patients with cardiac or respiratory failure.

Among these, Veno-venous (VV) segment is expected to account for the largest share of the market in 2019. The large share of this segment is mainly attributed to the high incidence of respiratory failure, rising lung transplants, and technological advancements.

According to the U.S. National Institute of Health (NIH), a combination of venovenous and veno-arterial is used in specific cases, such as cardiogenic shock. The veno-arterial segment led the market in 2019.

Veno-arterial systems can be used for the treatment/management of decreased cardiac output and tissue hypoperfusion, which results in cardiogenic shock. This can act as a trigger for a myocardial infarction or chronic ischemia.

Source: DataM Intelligence Analysis (2020)

Based on Application, the global Extracorporeal Membrane Oxygenation Machine market is segmented into Respiratory, Cardiac, and Extracorporeal Cardiopulmonary Resuscitation (ECPR). The respiratory segment is expected to hold the major share in the market due to its crucial role in supporting pulmonary function and is projected to witness lucrative growth over the forecast period whereas the Increasing number of people suffering from chronic diseases such as obesity and diabetes, highly susceptible to suffer from cardiovascular conditions will drive the extracorporeal cardiopulmonary resuscitation (ECPR) market.

Source: DataM Intelligence Analysis (2020)

Based on Component, the global Extracorporeal Membrane Oxygenation Machine market is segmented into Pumps, Oxygenators, Controllers, Cannula, and Accessories.

Source: DataM Intelligence Analysis (2020)

Geographical Analysis

North America is expected to account for the largest share of the global market in 2018, followed by Europe, Asia-Pacific, and the Rest of the World. The large share of North America is due to the well-developed primary, secondary, and tertiary care hospitals, reimbursement framework, favorable government funding, and higher awareness about the ECMO systems facilitating their adoption in hospitals.

On the other hand, Asia Pacific is expected to be the fastest-growing regional market over the forecast period. This can be attributed to the increasing prevalence of lung cancer in countries, such as China and India. According to National Cancer Center (NCC), each year ~781,000 patients are diagnosed with lung cancer in China and is one of the leading causes of cancer deaths in the country.

Source: DataM Intelligence Analysis (2020)

Competitive Landscape

Some of the major manufacturers in the Extracorporeal Membrane Oxygenation Machine market are MAQUET Holding B. V. & Co. KG, Medtronic plc, LivaNova PLC. These companies together contributed XX% of the global market in 2019. The other players of the market are XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical Inc, ALung Technologies Inc, and EUROSETS S.r.l.

The key players are adopting various growth strategies such as new product launches, mergers & acquisitions, partnerships, and collaborations which are contributing to the growth of the Extracorporeal Membrane Oxygenation Machine market globally. For instance,

  • Terumo Cardiovascular Systems Corporation has made refinements in existing technology while manufacturing CAPIOX FX Oxygenator.
  • Medtronic Plc designed Minimax Plus Oxygen System with functions such as venous aerosols and low arterial ports, integrated into the system to enhance security and performance for patients (neonates and children).

Why Purchase the Report?

  • Visualize the composition of the Extracorporeal Membrane Oxygenation Machine market segmentation by product type and distribution channel highlighting the key commercial assets and players.
  • Identify commercial opportunities in Extracorporeal Membrane Oxygenation Machine market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of Extracorporeal Membrane Oxygenation Machine market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The Global Extracorporeal Membrane Oxygenation Machine Market report would provide an access to an approx. 61 market data table, 54 figures and 286 pages.

Target Audience

Trending Topics

Oxygen Concentrators Market

Extracorporeal Membrane Oxygenation System Market

Oxygen Therapy Market

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

Discount Applied



25% discount offer

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest